SAGILITY LIMITED

Sagility Limited reported strong financial performance for Q2 FY27, with consolidated revenue of INR 20,321 million ($212.6 million), representing a 22.5% year-on-year growth in INR terms and 12.2% in constant currency. Excluding the CareSeed acquisition, organic revenue growth was 22.2% in INR terms and 11.9% in constant currency. Adjusted EBITDA reached INR 5,353 million ($56 million), a 23% year-on-year increase, with a margin of 26.3%, the highest in six quarters. Adjusted PAT was INR 3,254 million ($34 million), up 8.1% year-on-year. For the half-year, revenue was INR 39,956 million ($420.4 million), growing 25% in INR terms and 13.7% in constant currency. Adjusted EBITDA was INR 10,069 million ($105.9 million), with a margin of 25.2%, and adjusted PAT was INR 5,951 million ($62.6 million), up 18.9% year-on-year. The company acquired Chirok Health LLC, enhancing its mid-cycle RCM capabilities and expanding its provider segment. Management guided toward a FY27 adjusted EBITDA margin of 25% to 26%, up from 24% previously. The company also announced an interim dividend of INR 0.15 per share. Management emphasized growth in AI-driven solutions, cross-selling opportunities, and operational efficiency, while noting challenges such as statutory wage revisions and seasonality in revenue. The company received several industry recognitions, including the Everest Group Elevate Honor and Avasant leadership recognition.

The document highlights strong revenue and profitability growth, successful acquisitions, and positive industry recognition, indicating a positive tone.